Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
InMed Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada 13
InMed Pharma Enters into Research and Development Agreement with ATERA 14
InMed Pharma Enters into Agreement with Pharmaseed 15
Revive Therapeutics to Enter into Agreement with InMed Pharma 16
InMed Pharma Enters into Agreement with University of Debrecen to Develop Novel Phytocannabinoid Therapies for Ocular Allergies 17
InMed Pharma Enters into Agreement with University of British Columbia 18
Cannabis Science Enters into Co-Development Agreement with ImmunoClin 19
Cannabis Science Enters Into Joint Venture With Dupetit Natural Products 20
Licensing Agreements 21
Cannabis Science Enters Into Licensing Agreement With Endocan 21
Equity Offering 22
InMed Pharma Raises USD11.5 Million in Public Offering of Units 22
InMed Pharma Raises USD1.6 million in Public Offering of Shares 23
InMed Pharma Raises USD7.3 Million in Private Placement of Units 24
InMed Pharma Raises USD1 Million in Private Placement of Units 25
InMed Pharma Raises USD4.3 Million in Public Offering of Units 26
InMed Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Warrants 28
InMed Pharma Raises USD0.2 Million in Private Placement of Units 29
InMed Pharma to Raise USD0.7 Million in Private Placement of Units 30
InMed Pharma Raises USD0.83 Million in Private Placement of Units 31
InMed Pharma Raises USD0.8 Million in Private Placement of Units 32
Cannabis Science Raises USD1 Million in Private Placement of Shares 33
Asset Transactions 34
X-Change Acquires Phytiva Brand Of Products From Cannabis Science 34
Acquisition 35
Cannabis Science Acquires Additional 30.1% Stake in Michigan Green Technologies 35
Cannabis Science to Acquire Canada-Based Medical Cannabis Provider 36
X-Change Acquires Germany-Based Joint Venture Company From Cannabis Science And Dupetit Natural Products 37
Cannabis Science Acquires Trimcare, Provider Of Healthcare Facilities 38
InMed Pharmaceuticals Inc – Key Competitors 39
InMed Pharmaceuticals Inc – Key Employees 40
InMed Pharmaceuticals Inc – Locations And Subsidiaries 41
Head Office 41
Recent Developments 42
Financial Announcements 42
Sep 13, 2018: InMed Pharmaceuticals reports fourth quarter and full year fiscal 2018 financial results and provides R&D and business update 42
May 11, 2018: InMed Reports Third Quarter Fiscal 2018 Financial Results and Provides Business Update 44
Corporate Communications 46
May 04, 2018: OTC Markets Group Welcomes InMed Pharmaceuticals to OTCQX 46
May 01, 2018: InMed Names Dr. Vikramaditya G. Yadav To Scientific Advisory Board 47
Apr 11, 2018: InMed Announces Appointment of Joshua Blacher as Chief Business Officer 48
Mar 23, 2018: InMed Pharmaceuticals Announces Graduation to Toronto Stock Exchange 49
Mar 02, 2018: InMed Receives Conditional Approval to List on the Toronto Stock Exchange 50
Oct 10, 2017: InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board 51
Jan 13, 2017: InMed Pharmaceuticals Appoints Martin Bott to Board of Directors 52
Government and Public Interest 53
Sep 11, 2018: InMed Pharmaceuticals announces NSERC grant to The University of British Columbia in support of collaborative R&D work 53
Product News 54
Oct 24, 2017: InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid 54
07/27/2017: InMed Announces Publication in European Journal of Pain 55
Mar 06, 2018: InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research 56
Clinical Trials 57
Oct 17, 2017: InMed Updates Pain Program 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
InMed Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
InMed Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada 13
InMed Pharma Enters into Research and Development Agreement with ATERA 14
InMed Pharma Enters into Agreement with Pharmaseed 15
Revive Therapeutics to Enter into Agreement with InMed Pharma 16
InMed Pharma Enters into Agreement with University of Debrecen to Develop Novel Phytocannabinoid Therapies for Ocular Allergies 17
InMed Pharma Enters into Agreement with University of British Columbia 18
Cannabis Science Enters into Co-Development Agreement with ImmunoClin 19
Cannabis Science Enters Into Joint Venture With Dupetit Natural Products 20
Cannabis Science Enters Into Licensing Agreement With Endocan 21
InMed Pharma Raises USD11.5 Million in Public Offering of Units 22
InMed Pharma Raises USD1.6 million in Public Offering of Shares 23
InMed Pharma Raises USD7.3 Million in Private Placement of Units 24
InMed Pharma Raises USD1 Million in Private Placement of Units 25
InMed Pharma Raises USD4.3 Million in Public Offering of Units 26
InMed Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Warrants 28
InMed Pharma Raises USD0.2 Million in Private Placement of Units 29
InMed Pharma to Raise USD0.7 Million in Private Placement of Units 30
InMed Pharma Raises USD0.83 Million in Private Placement of Units 31
InMed Pharma Raises USD0.8 Million in Private Placement of Units 32
Cannabis Science Raises USD1 Million in Private Placement of Shares 33
X-Change Acquires Phytiva Brand Of Products From Cannabis Science 34
Cannabis Science Acquires Additional 30.1% Stake in Michigan Green Technologies 35
Cannabis Science to Acquire Canada-Based Medical Cannabis Provider 36
X-Change Acquires Germany-Based Joint Venture Company From Cannabis Science And Dupetit Natural Products 37
Cannabis Science Acquires Trimcare, Provider Of Healthcare Facilities 38
InMed Pharmaceuticals Inc, Key Competitors 39
InMed Pharmaceuticals Inc, Key Employees 40
List of Figures
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
InMed Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10